Genesco (GCO) Teardown: Journeys or Nothing

$155.6 million in operating income in FY2022. $17.3 million in FY2026. Revenue over that same four-year span went from $2.42B to $2.44B -- essentially flat. Operating income fell 89%.

That compression story is Genesco in a single data point. A $2.4B specialty footwear retailer operating at a 0.7% GAAP margin in what management describes as a recovery year. The structural question is not whether the recovery is real. It is whether a business at this operating-margin level can earn its cost of capital when revenue is flat and occupancy costs are fixed.

The answer depends almost entirely on one banner: Journeys.

Section 1 - The snapshot

Fiscal year	Net sales	YoY	Gross margin	Operating margin	GAAP net income	Diluted EPS
FY2022 (ended Jan 29, 2022)	$2,422M	n/a	48.8%	6.4%	$114.9M	$7.92
FY2023 (ended Jan 28, 2023)	$2,385M	-1.5%	47.6%	3.9%	$71.9M	$5.66
FY2024 (ended Feb 3, 2024)	$2,325M	-2.5%	47.3%	-0.6%	-$16.8M	-$1.50
FY2025 (ended Feb 1, 2025)	$2,325M	0.0%	47.2%	0.6%	-$18.9M	-$1.74
FY2026 (ended Jan 31, 2026)	$2,436M	+4.8%	46.3%	0.7%	$13.3M	$1.25

Metric	FY2026 (full year)	Q1 FY2027 (ended May 2, 2026)	Q1 FY2026 (prior year)
Net sales	$2,436.1M	$487.0M	$474.0M
Revenue YoY	+4.8%	+2.8%	n/a
Gross margin	46.3%	47.0%	46.7%
GAAP operating income (loss)	$17.3M (0.7%)	-$15.4M (-3.2%)	-$28.1M (-5.9%)
GAAP net income (loss)	$13.3M	-$14.8M	-$21.2M
Diluted EPS	$1.25	-$1.42	-$2.02
Total comparable sales	+6%	+2%	+5%
Cash	$105.4M	$27.1M	$21.7M
Long-term debt	$3.4M	$45.3M	$121.0M
Inventory	$433.9M	$476.9M	n/a

Section 2 - The business model: how Genesco actually makes money

Genesco reports four operating segments. Understanding how money flows through each is the starting point for understanding why the consolidated margin is so thin.

Journeys Group (61.4% of FY2026 sales, 965 stores): Mall and outlet-center stores targeting teens aged 13-22. The stores carry branded footwear from Nike, Vans, Converse, Timberland, New Balance, and others. Revenue is purely DTC retail. The product is trend-driven footwear, not Genesco-manufactured product -- the company is a buyer and a storekeeper, not a brand house. FY2026 Journeys Group comparable sales: +9%. Segment operating margin: 4.05%.

Schuh Group (20.5%, 118 stores): UK and Ireland specialty footwear targeting 16-24 year olds. The highest e-commerce penetration in the portfolio -- "over 45%" of Schuh's FY2026 segment sales ran through schuh.co.uk and related digital channels. FY2026 segment operating income: -$4.5M. The top line received a $21.2M FX translation tailwind from sterling strength; without it, the loss would have been larger.

Johnston and Murphy Group (13.1%, 153 stores): Premium men's and women's footwear and apparel in retail stores, factory stores, and department-store wholesale. Within J&M, retail was 77.9% of segment FY2026 sales; wholesale (better department stores, specialty retailers) was 22.1%. Higher average unit retail than Journeys. Segment operating margin: 1.43% in FY2026, turning more constructive in Q1 FY2027 (+7% comp).

Genesco Brands Group (5.0%, wholesale only): Licensed wholesale of footwear under the Wrangler, Dockers, and STARTER names. No retail stores. The company is actively exiting the Levi's license as it expires in May 2026 -- a deliberate move to improve mix but a ~$30M near-term revenue headwind for FY2027.

Where the 46.3% gross margin comes from: Genesco buys branded footwear from Nike, Vans, and other vendor-owned brands, marks it up, and sells it through owned stores. There is no owned manufacturing. The margin is the retail markup on third-party branded product, less cost-of-sales allowances, freight, and markdown. The Journeys teen consumer is price-elastic -- when fashion misfires, markdowns hit the gross margin line quickly. The 90bps gross-margin compression in FY2026 despite positive comps reflects exactly this: cost-of-sales grew 6.6% on 5.0% revenue growth, meaning input-cost inflation (freight, tariffs, product) outpaced pricing power.

E-commerce represented approximately 23-25% of total retail sales in FY2026 (per management commentary), with e-comm comparable sales up 4% for the year while store comps were +6%. Genesco does not break out advertising expense separately from SGA -- a disclosure gap that makes it difficult to assess the marketing-to-revenue efficiency.

Section 3 - Strengths: what holds up under pressure

1. A real gross-margin premium over specialty-footwear peers. Genesco's 46.3% FY2026 GAAP gross margin is approximately 400 basis points above Designer Brands' 42.4% (FY2026) and over 1,700 basis points above Foot Locker's 29.1% (FY2025). That gap is structural: the DTC-heavy specialty model with branded footwear at premium price points earns more gross margin per dollar of revenue than a licensed-footwear wholesaler or an athletic-specialist chain running vendor-financed inventory programs. A CFO underwriting GCO is buying a genuine margin premium, not a hypothetical one.

2. Seven consecutive quarters of positive comparable sales through Q1 FY2027. Starting from a trough that included operating losses in FY2024 and net losses in FY2024 and FY2025, the company has produced positive total comp sales for seven consecutive quarters. Journeys posted +9% full-year FY2026 comps and +5% in Q1 FY2027. J&M inflected from -2% in Q1 FY2026 to +7% in Q1 FY2027. These are not manufactured numbers -- they represent actual same-store revenue growth against prior-year periods that weren't soft.

3. A balance sheet that can absorb a bad quarter. On a traditional financial-debt basis, FY2026 year-end showed $105.4M of cash against $3.4M of revolver borrowings -- $102M of net cash. The revolving credit facility provides $332.5M of total commitments with $305.7M of excess availability at January 31, 2026. Management is self-funding a $40-50M cost-reduction program and a planned net store reduction of approximately 52 stores in FY2027 without diluting equity. The caveat: $398.8M of long-term operating lease liabilities (plus current portion) make this a lease-heavy balance sheet, not a clean one.

Section 4 - Weaknesses: what the 10-K and 10-Q actually reveal

1. Journeys produces all the profit. Not most of it -- all of it. FY2026 Journeys Group segment operating income: $60.5M. Total segment operating income across all four segments: $60.5M (the non-Journeys segments sum to approximately zero: J&M $4.6M + Schuh -$4.5M + Genesco Brands -$0.1M). Subtract $35.1M of unallocated corporate SGA and approximately $8.1M of asset impairments and other charges, and consolidated operating income reaches $17.3M. Remove Journeys from the equation and this is a $35M+ operating-loss business. The company markets itself as a "four-segment diversified footwear platform" -- the numbers say single-banner concentration with three bolt-on businesses that collectively break even in a good year.

When I talk to founders running a retail business with this concentration profile, the same pattern surfaces: one hero product or one hero category that carries the P&L, surrounded by adjacent bets that feel like diversification but are too small to matter in the bad quarter. The tell is not the revenue mix -- it is the operating-income mix. Genesco's segment data makes the concentration undeniable.

2. Operating margin is structurally sub-1%, and the gross-margin compression has not reversed. FY2022 operating margin was 6.4%. FY2026 is 0.7%. Revenue is essentially flat over that period. The 570bps of operating margin compression over four years on flat revenue reflects SGA creep: SGA was 42.7% of revenue in FY2022 and 45.2% in FY2026. A 90bps gross margin compression in FY2026 (47.2% to 46.3%) absorbed the 120bps of SGA leverage the company achieved on the same period -- meaning the cost savings are being offset by rising input costs. Three consecutive -100bps quarterly gross-margin prints in Q2, Q3, and Q4 of FY2026 are the data series that invalidates the "margin recovery" narrative. Q1 FY2027's +30bps is one quarter of improvement, not a confirmed trend.

3. Schuh is a structural drag concealed by FX. Schuh's FY2026 operating loss of $4.5M looks modest. But the 10-K explicitly discloses that Schuh's FY2026 net sales were "positively impacted by $21.2 million due to the change in foreign exchange rates." The sterling-USD translation tailwind inflated the revenue line by $21.2M but the operating loss only improved by $0.2M from FX. Strip the FX benefit and Schuh's underlying operating performance looks structurally worse than the reported segment loss suggests. Q1 FY2027 brought the structural picture into focus: Schuh comparable sales -9% against a +1% prior-year quarter -- a 1,000bps sequential deceleration. Management's statement that the Schuh turnaround "will take longer than Journeys" is an acknowledgment of structural difficulty, not a near-term catalyst.

4. The inventory build is accelerating at precisely the wrong time. The Q1 FY2027 10-Q discloses verbatim: "There was a $43.2 million increase in inventory in the first three months of Fiscal 2027, compared to a $20.2 million increase in the first three months of Fiscal 2026." The build rate more than doubled. Inventory at May 2, 2026 was $476.9M, up 6% year-over-year. Days inventory outstanding expanded from approximately 121 days at FY2026 year-end to approximately 133 days in Q1 FY2027. This inventory build coincides with decelerating comparable sales (+2% total comp in Q1 FY2027 vs. +5% prior year). The classic early-warning configuration: forward merchandise bets placed against a demand picture that is softening.

5. The leadership void at the CFO level is a governance flag. CFO Cassandra Harris departed March 6, 2026. CEO Mimi Vaughn has been serving simultaneously as Board Chair, President and CEO, and Interim CFO since that date -- now approaching four months without a permanent CFO appointment. For a $2.4B NYSE issuer in the middle of a cost-restructuring program and a multi-segment turnaround, a single executive holding all three roles creates alignment risk. The same person setting cost targets, executing them, and reporting on them to the board is the functional definition of a weak check-and-balance structure.

Section 5 - Opportunities and threats

The most credible near-term opportunity is the $40-50M cost-reduction program announced alongside Q1 FY2027 results. It targets run-rate savings through FY2029, focused on occupancy and corporate costs rather than marketing -- management has been explicit that marketing spend supports the positive-comp trajectory and cannot be the primary lever. If the program delivers at the $40M threshold, it adds roughly 1.6 percentage points to the current operating margin. That converts the FY2027 operating-margin profile from sub-1% to something approaching 2-2.5% -- still thin for a $2.4B retailer, but enough to make the EPS trajectory credible.

The $23-25M of expected IEEPA tariff refunds are a genuine one-time cash inflow that management has quantified and will receive. The size of the refund is itself the tell: it approximates the magnitude of the excess duty Genesco paid in the prior tariff cycle on footwear imported from Vietnam, China, and India. This is a 2026 calendar-year tailwind, not a structural improvement.

Johnston and Murphy's Q1 FY2027 +7% comparable sales -- a 900bps improvement from -2% in the prior year -- is the most underappreciated segment story. J&M carries higher average unit retail than Journeys and has a wholesale arm serving better department stores. If the J&M comp holds through FY2027, it shifts the non-Journeys segment mix slightly in favor of positive operating income, reducing the total concentration risk.

The threats are more structural. Mall traffic has been declining as a percentage of total retail activity, and Journeys' 741-store fleet is predominantly mall-based. A Journeys comp deceleration below flat -- not even a reversal, just a deceleration below zero -- pushes the consolidated enterprise into operating-loss territory given the current SGA structure. The 10-K states verbatim: "inflationary pressure on the products we sell might limit our ability to pass on cost increases to our customers resulting in gross margin impact or reduced demand." Footwear from Vietnam and China carries ongoing tariff exposure. And the Levi's license exit removes approximately $30M of FY2027 revenue from Genesco Brands with no confirmed replacement at equivalent scale.

Section 6 - The macro environment

Three forces are directly shaping Genesco's operating window.

Teen discretionary spending is the most concentrated force. Journeys' teen customer is 13-22 years old, purchasing fashion-forward branded footwear on a trend-pull cycle. The FY2026 recovery -- +9% Journeys comp for the full year -- ran on a genuine demand tailwind: teen sneaker culture remained strong, Nike and Vans remained relevant at the price points Journeys carries, and back-to-school and holiday spending was solid. Q1 FY2027's deceleration to +5% Journeys comp is a read on the spring demand environment. Management's own FY2027 comparable sales guidance of +1% to +2% implies the run-rate is normalizing, not accelerating.

UK consumer and FX exposure at Schuh is the international macro dimension. The UK consumer is navigating a cost-of-living pressure environment that is distinct from US conditions. Schuh's -9% Q1 FY2027 comp reflects a combination of deliberate promotion pullback (management is cutting promotional intensity to reset ticket prices) and genuine demand softness. Sterling volatility adds another layer: the $21.2M FX tailwind in FY2026 translated GBP revenue at favorable rates; any sterling weakness reverses this on the top line.

Tariff and sourcing exposure is the supply-chain macro factor. Genesco sources a meaningful share of inventory from Vietnam, China, and India. The 10-K risk-factor section names all three explicitly. The expected $23-25M IEEPA refund confirms that prior-period tariff escalation was a real gross-margin headwind, not a footnote. Any renewed tariff increase on footwear imports -- a category that has historically been a target in US-Asia trade negotiations -- would hit the gross-margin line within one quarter.

Section 7 - The CFO verdict and the operator bridge

The Street's thesis on GCO is numerically dispersed but directionally aligned: no sell-side firm with public coverage is at a Sell rating. The debate is over the multiple. Jefferies holds at $29 (~16x mid-point FY2027 adjusted EPS), Truist holds at $40 (~22x), Williams Trading initiates at Buy with a $39 target. The spread is essentially one question: are the seven consecutive positive comp quarters a structural inflection that justifies re-rating toward 20x earnings, or a cyclical recovery from a depressed base that keeps the stock anchored at 14-16x?

Where the Eightx read agrees with the bears: the 5-year average ROIC of approximately 3.4% (per independent research) is below the cost of capital for a leveraged retail model, and it does not depend on calling the next comp quarter to be true. A business that earns 3.4% average ROIC over a full cycle while carrying $400M+ of operating lease obligations is not creating equity value -- it is treading water. The "recovery" in FY2026 produced $17.3M of GAAP operating income on $2.44B of revenue. That is not a profitable return on the capital deployed across 1,236 stores, the ROU asset base, and the working capital.

Where the Eightx read disagrees with the bears: the gross-margin premium (46.3% vs. peers in the low-40s) is real, not manufactured. Journeys' 4% segment operating margin on $1.5B of sales is a genuine indication that the banner earns its keep in a positive-comp environment. The risk is not that the underlying unit economics are broken -- the risk is concentration and seasonality.

The differentiated thesis that the Street commentary mostly misses: Genesco's operating-income profile is not just Journeys-concentrated -- it is Q4-concentrated within Journeys. Derived Q4 FY2026 operating income is approximately $51M on approximately $800M of revenue (6.4% quarterly margin). The three non-holiday quarters produce negative to barely-positive operating income. This is what "the holiday quarter carries the year" looks like at the financial statement level. Every operating decision -- inventory bets, marketing spend, lease renewals, cost programs -- is ultimately a bet on a six-to-eight-week window in November and December. If Journeys misses a holiday quarter, there is no other quarter to recover in.

The operator bridge. The Genesco pattern shows up in a smaller version at most founder-led retail brands that I have worked with or watched closely. It is the single-hero-product, single-season concentration -- the business where Q4 revenue is 40-50% of the annual total and Q4 is also 90%+ of the annual operating profit. The warning signal is not a bad quarter. It is when the gap between the holiday-quarter margin and the full-year reported margin starts widening, because it means the non-holiday business is compressing.

At $5-30M in annual revenue, the Genesco pattern shows up as a single hero SKU and a single hero season. The founders I see building in this model typically track revenue religiously but do not track operating income by quarter. They assume the holiday pull carries forward into January and February. It does not -- it snaps back to the underlying cost base, which is fixed on a monthly basis. Three months into the new year, they are confused about why cash is tighter than the P&L suggested. The answer is that the P&L was a holiday-quarter P&L and the cost base is a twelve-month cost base.

The early-warning scorecard for this pattern:

1. Quarterly operating-income decomposition: calculate operating income (or loss) for each quarter. If Q4 is more than 80% of the annual total, the business is a single-season bet. If Q4 is 100%+ (meaning three other quarters are collectively losing money), you need to know that before you commit to any lease renewals, headcount builds, or inventory forward bets.
2. Comparable sales trend velocity, not level: a comp at +5% that is decelerating from +9% is a different risk profile than a comp at +5% that is accelerating from +2%. Track the direction, not just the number. Genesco's Q1 FY2027 +2% total comp is directionally down from +5% the prior year; management's own FY2027 guidance of +1% to +2% implies the deceleration is real.
3. Inventory build rate vs. comp trend: the ratio of current-quarter inventory dollar-build to prior-year same-quarter inventory build is the leading indicator. Genesco's Q1 FY2027 ratio was 2.1x ($43.2M vs. $20.2M). A 2x or greater ratio in a quarter with decelerating comps is a classic setup for markdown pressure in the following two to three quarters.
4. Non-hero segment operating-income contribution: if your hero segment is growing but the secondary segments are still losing money at the segment level, you have not built a second engine -- you have built a larger single-engine with expensive passengers.
5. Operating lease liabilities as a percentage of annual revenue: Genesco's long-term operating lease liabilities of $398.8M represent approximately 16% of annual revenue. For a business earning 0.7% operating margin, that is a fixed-cost structure that leaves almost no room for revenue deceleration.

Run this framework against your own numbers before the inventory bill arrives. A fractional CFO conversation can be completed in one session; discovering the problem in the quarterly results costs significantly more.

Related teardowns and live indexes

For more specialty retail and footwear teardowns, read the Boot Barn teardown and the Urban Outfitters teardown. To benchmark Genesco against the public-DTC leaderboard and track margin trends across the sector, visit the Public DTC Leaderboard and the DTC Cost-of-Goods Index.

Sources and methodology

SEC EDGAR is the primary source for every financial figure in this teardown. Genesco Inc. (CIK 0000018498) files on SEC EDGAR under ticker GCO, NYSE. Filings used: 10-K FY2026 (filed March 25, 2026); 10-K FY2025 (filed March 26, 2025); 10-K FY2024 (filed March 27, 2024); 10-K FY2023 (filed March 22, 2023); 10-K FY2022 (filed March 23, 2022); 10-Q Q1 FY2027 (filed June 11, 2026). Revenue, gross margin, operating income, net income, diluted EPS, SGA, inventory, cash, and debt figures are sourced from XBRL financial data in these filings. The full 10-K filing index for GCO on SEC EDGAR links to all historical annual reports.

Segment operating income data is from Note L (Segment Information) in the Genesco 10-K FY2026. The Journeys $60.5M, Schuh -$4.5M, Johnston and Murphy $4.6M, and Genesco Brands -$0.1M figures are segment-reported and sum to total segment operating income of $60.5M before unallocated corporate SGA ($35.1M) and asset impairments. The consolidated operating income of $17.3M is the 10-K line item, not a derived figure.

Derived Q4 FY2026 operating figures are calculated by subtracting the three reported quarterly periods (Q1 FY2026 ended May 3, 2025; Q2 FY2026 ended August 2, 2025; Q3 FY2026 ended November 1, 2025) from the FY2026 full-year 10-K totals. These derived figures are clearly labeled as such.

Schuh FX disclosure is quoted verbatim from the Genesco 10-K FY2026 MD&A: "Schuh Group's net sales for Fiscal 2026 were positively impacted by $21.2 million and the operating loss for Fiscal 2026 was negatively impacted by $0.2 million due to the change in foreign exchange rates." Source: Genesco FY2026 earnings release.

Inventory build disclosure is verbatim from the Q1 FY2027 10-Q: "There was a $43.2 million increase in inventory in the first three months of Fiscal 2027, compared to a $20.2 million increase in the first three months of Fiscal 2026." Source: GCO 10-Q Q1 FY2027.

Q1 FY2027 earnings release and guidance (adjusted diluted EPS $2.00-$2.40, comparable sales +1% to +2%, cost-reduction program $40-50M, IEEPA refunds $23-25M) is sourced to the Genesco Q1 FY2027 earnings release, dated May 29, 2026. Adjusted EPS guidance is a non-GAAP measure; GAAP EPS guidance was not separately provided.

Analyst coverage is sourced to publicly available ratings: Truist Securities Hold $40 (maintained June 1, 2026); Jefferies Hold raised to $29; Williams Trading Buy $39 (initiated January 12, 2026). MarketBeat aggregator consensus: Moderate Buy, $36.67 average price target (5-analyst universe). These are sell-side opinions, not audited facts, and reflect dated coverage that may not account for subsequent developments. Source: Trefis two-speed turnaround analysis (June 2, 2026); MarketBeat GCO analyst ratings.

Peer gross-margin comparison: Designer Brands 42.4% is from the Designer Brands FY2026 earnings release (fiscal year ended January 31, 2026). Foot Locker 29.1% is from the Foot Locker FY2025 annual report. These are GAAP gross margins from public filings.

Limitations. Genesco does not separately disclose advertising or marketing expense as a line item. Third-party marketplace revenue is described as an "increasing amount" in the 10-K but is not quantified as a percentage. Capital expenditures are in the 10-K cash-flow statement but are not in the XBRL data reviewed here; readers should consult the primary filing. Operating lease obligations are a substantial component of total obligations but are presented separately from financial debt throughout this teardown -- the traditional net-cash position of $102M at FY2026 year-end is correct on a financial-debt basis but does not reflect the full lease commitment structure.

Frequently asked questions

why does genesco make so little profit on $2.4 billion in revenue?

The business model is specialty retail with fixed-cost occupancy in malls. Cost of sales runs at 53.7% of revenue and SGA (primarily rent and store labor) runs at 45.2%, leaving 0.7% as operating income. The math requires a very high comparable-sales base to generate acceptable returns -- and when comps fall even slightly negative, the operating income turns negative immediately. The FY2024 operating loss of $13.5M on $2.32B of revenue is what -0.6% operating margin looks like at scale. Source: GCO 10-K FY2026 (SEC EDGAR XBRL data).

what percentage of genesco's profit comes from the journeys banner?

Essentially 100%, and then some. In FY2026, Journeys Group produced $60.5M of segment operating income on $1,494.6M of sales (4.05% segment margin). The other three segments combined produced approximately $0M of net segment operating income ($4.6M from J&M, minus $4.5M from Schuh, minus $0.1M from Genesco Brands). After $35.1M of unallocated corporate overhead, consolidated operating income was $17.3M. Source: GCO 10-K FY2026 Note L.

what is genesco's schuh business and why does it keep losing money?

Schuh is Genesco's UK and Ireland specialty footwear chain with 118 stores, targeting 16-24 year olds. It generated $500M of FY2026 revenue (20.5% of total) but posted a segment operating loss of $4.5M. Q1 FY2027 comparable sales fell -9% (vs. +1% prior year). The business runs against UK consumer discretionary headwinds, and management has publicly stated the turnaround "will take longer than Journeys." Source: GCO 10-K FY2026; Q1 FY2027 earnings release.

how seasonal is genesco's business?

Extremely seasonal. The holiday quarter (Q4, ending late January) carries essentially the entire year. In FY2026, the first three fiscal quarters combined generated an estimated net operating loss -- while Q4 FY2026 produced approximately $51M of operating income on approximately $800M of revenue (derived from annual less Q1-Q3 actuals). Q1 is structurally loss-making in every year; even Q1 FY2027 with positive comps generated a $15.4M GAAP operating loss. Source: GCO 10-K FY2026; 10-Q Q1 FY2027.

what is genesco's gross margin and how does it compare to competitors?

Genesco's FY2026 GAAP gross margin was 46.3%, down 90bps from 47.2% in FY2025 following three consecutive -100bps quarters. That is approximately 400bps above Designer Brands' 42.4% gross margin (FY2026) and 1,700+ bps above Foot Locker's 29.1% (FY2025) -- the DTC-heavy specialty model earns a real premium. But the premium has eroded from 48.8% in FY2022. Source: GCO 10-K FY2026; Designer Brands and Foot Locker public filings.

is genesco's cfo role filled right now?

No. CFO Cassandra Harris departed effective March 6, 2026. CEO Mimi Vaughn (in seat since February 2020) has been serving as Interim Chief Financial Officer since that date. As of the Q1 FY2027 10-Q filing (June 11, 2026), no permanent CFO replacement has been announced -- a non-trivial governance flag for a $2.4B NYSE issuer in the middle of a cost-restructuring program. Source: Genesco CFO transition press release, January 29, 2026.

what is genesco's debt and cash position?

On a traditional financial-debt basis, Genesco entered FY2027 in a strong position: $105.4M of cash against only $3.4M of revolver borrowings at January 31, 2026. However, the company carries $398.8M of long-term operating lease liabilities (plus current portion), which are the fixed costs of its 1,236 mall stores -- the functional equivalent of structural obligations. By Q1 FY2027 (May 2, 2026), cash fell to $27.1M and revolver borrowings rose to $45.3M, driven by the seasonal inventory build. Source: GCO 10-K FY2026; 10-Q Q1 FY2027.

what is genesco's fy2027 guidance and cost-reduction plan?

Management raised adjusted diluted EPS guidance to $2.00-$2.40 for FY2027 (adjusted non-GAAP), with comparable sales expected at +1% to +2% and total sales -1% to flat. A new $40-50M cost-reduction program targets run-rate savings through FY2029. Additionally, Genesco disclosed expected IEEPA tariff refunds of approximately $23-25M (a one-time cash inflow). Source: Q1 FY2027 earnings release, May 29, 2026.